Ventas, Inc. Profile Avatar - Palmy Investing

Ventas, Inc.

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real est…
REIT - Healthcare Facilities
US, Chicago [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -2.02 67.82 69.22
Graham Fair Price -60.52 4.31 10.93
PEG 79.41 3.57 -1.99
Price/Book -13.15 1.84 2.12
Price/Cash Flow 17.11 130.65 111.56
Prices/Earnings -446.20 -301.99 -55.29
Price/Sales -16.47 14.41 17.25
Price/FCF 17.11 130.65 111.56
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -69.57 0.18 -0.58
Operating Margin -79.12 0.12 -0.59
ROA 84.21 < 0.005 < 0.005
ROE < 0.005 < 0.005 84.10
ROIC -0.03 < 0.005 -82.72
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 0.01 -94.45
Dividends QOQ < 0.005 < 0.005 86.24
EBIT QOQ -53.12 1.22 -97.71
EPS QOQ -0.28 0.85 204.43
FCF QOQ -0.39 -0.27 32.60
Revenue QOQ 0.01 0.03 140.92
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 66.37 100.00
Days Sales Outstanding (DSO) 15.00 19.16 27.70
Inventory Turnover 0.00 1.36 100.00
Debt/Capitalization 0.59 0.59 0.59
Quick Ratio 0.64 0.81 27.06
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 23.54 23.31 -0.99
Cash 1.40 1.71 22.06
Capex -0.25 -0.33 -35.29
Free Cash Flow 0.45 0.33 -26.57
Revenue 2.89 2.97 2.96
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.73 0.85 15.72
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 27.46 29.20 6.34
Naive Interpretation Member
06 - Financial Health · Bad
End of VTR's Analysis
CIK: 740260 CUSIP: 92276F100 ISIN: US92276F1003 LEI: - UEI: -
Secondary Listings